James P. Allison, Ph.D.

The University of Texas at MD Anderson Cancer Center

CRI Scientific Advisory Council director James Allison explains why "taking the brakes off" T cells is a good way to fight cancer.

Ian H. Frazer, AC, FRS, FAA

The University of Queensland, Australia

The CRI Clinical Investigator is modest about his contribution to the development of the recently-announced breakthrough cervical cancer vaccine.

Carl H. June, M.D.

University of Pennsylvania

Pancreatic cancer patients will be enrolled in a clinical trial of a new immunotherapy that harnesses the immune system’s ability to fight pancreatic cancer.

Hyam I. Levitsky, M.D.

Johns Hopkins University

Dr. Levitsky is in a unique position to facilitate academic-industry partnerships that will advance the development of cancer immunotherapies.

Kunle Odunsi, M.D., Ph.D.

Roswell Park Cancer Institute

CRI physician-scientist Kunle Odunsi, M.D., Ph.D., is leading the way in cancer immunotherapy for ovarian cancer.

Corrie Painter, Ph.D.

University of Massachusetts

Angiosarcoma patient and CRI postdoctoral fellow Dr. Corrie Painter is studying how immune cells in zebrafish can fight against hers and other cancers.

David A. Reardon, M.D.

Dana-Farber Cancer Institute

For glioblastoma, the most dangerous and aggressive form of brain cancer, fewer than 10 percent of patients survive more than 5 years. Dr. Reardon wants to change that.

Antoni Ribas, M.D., Ph.D.

University of California, Los Angeles

Dr. Ribas, of UCLA, discusses his latest immunotherapy clinical trials and how it'll transform cancer treatment.

Robert Schreiber, Ph.D.

Washington University School of Medicine

By redefining our understanding of the relationship between cancer and the immune system, Dr. Robert Schreiber has brought us closer to cures for cancer

Padmanee Sharma, M.D., Ph.D.

The University of Texas at MD Anderson Cancer Center

Dr. Sharma's translational research focuses on learning how to apply immune-based therapeutic strategies to manipulate components of the human immune system to lead to tumor regression.

Ralph Steinman, M.D.

The Rockefeller University

Dr. Steinman discusses his pioneering research on the role of dendritic cells in the immune system's response to cancer.

Jedd D. Wolchok, M.D., Ph.D.

Memorial Sloan Kettering Cancer Center

The leading immunotherapy expert knows better than almost anyone what clinical trials can do for patients.